Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma protein synthesis stimulation describes an increase in the biosynthesis and secretion of plasma proteins, primarily in liver hepatocytes, but also in plasma cells and other secretory cells. This process is governed chiefly by amino acid availability, nutrient-sensing pathways like mTOR, and hormonal/cytokine regulation. Increased production of albumin, globulins, fibrinogen, and other plasma proteins is observed in many physiological states (such as after feeding, in the acute-phase response, or in compensation for urinary protein loss in nephrotic syndrome). The process is not attributable to a single molecular target, but rather to concerted transcriptional and translational upregulation influenced by various upstream signaling molecules and factors.
Amino acid and nutrient sensing via the mTOR pathway; Hormonal regulation (e.g., insulin, glucagon); Regulation by cytokines and growth factors; Intracellular signaling controlling translation rates.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma protein synthesis stimulation.